NYSE: BHVNBiohaven Ltd Stock Ownership - Who owns Biohaven?
Insider buying vs selling
Have Biohaven Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John W. Childs | Director | 2025-03-04 | 25,000 | $30.39 | $759.65kBuy |
| John W. Childs | Director | 2025-03-04 | 900 | $30.73 | $27.65kBuy |
| John W. Childs | Director | 2025-03-04 | 3,400 | $30.73 | $104.47kBuy |
| John W. Childs | Director | 2025-03-04 | 3,400 | $30.73 | $104.47kBuy |
| George C. Clark | VP Chief Accounting Officer | 2025-01-05 | 1,117 | $38.64 | $43.16kSell |
| Bruce Car | Chief Scientific Officer | 2025-01-05 | 2,331 | $38.64 | $90.07kSell |
| Kimberly Gentile | SVP Clinical Operations | 2025-01-05 | 1,956 | $38.64 | $75.58kSell |
| Vlad Coric | Chief Executive Officer | 2025-01-05 | 6,805 | $38.64 | $262.95kSell |
| Matthew Buten | Chief Financial Officer | 2025-01-05 | 2,561 | $38.64 | $98.96kSell |
| John W. Childs | Director | 2024-12-30 | 29,000 | $35.95 | $1.04MBuy |
BHVN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BHVN insiders and whales buy or sell their stock.
BHVN Shareholders
What type of owners hold Biohaven Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John W. Childs | 11.85% | 12,095,747 | $246.39M | Insider |
| Vanguard Group Inc | 8.24% | 8,414,120 | $171.40M | Institution |
| Blackrock Inc | 7.51% | 7,667,188 | $156.18M | Institution |
| Janus Henderson Group PLC | 6.84% | 6,982,425 | $142.23M | Institution |
| Stifel Financial Corp | 6.43% | 6,559,313 | $133.61M | Institution |
| Suvretta Capital Management LLC | 5.51% | 5,620,271 | $114.48M | Institution |
| Vlad Coric | 4.82% | 4,916,101 | $100.14M | Insider |
| Farallon Capital Management LLC | 4.34% | 4,428,167 | $90.20M | Institution |
| State Street Corp | 3.44% | 3,512,478 | $71.55M | Institution |
| Price T Rowe Associates Inc | 3.34% | 3,412,191 | $69.51M | Institution |
BHVN vs Biotech Stocks
Biohaven Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.